Calcergy inhibited by calciphylactic challengers.
The subcutaneous calcification effected in the rat at sites directly treated with calcergens, such as lead acetate, CeCl(3), CaCl(2), and KMnO(4), is inhibited by simultaneous local application of various calciphylactic challengers, but not by many other compounds.
D000535:Aluminum / Q000494:pharmacology*; D000818:Animals; D002115:Calciphylaxis / Q000139:chemically induced*; D002122:Calcium Chloride; D002563:Cerium; D002857:Chromium / Q000494:pharmacology*; D003864:Depression, Chemical; D003998:Dicarboxylic Acids; D007501:Iron / Q000494:pharmacology*; D007505:Iron-Dextran Complex / Q000494:pharmacology*; D007854:Lead; D011196:Potassium Permanganate; D051381:Rats; D013012:Sorbitol; D014001:Tin / Q000494:pharmacology*
D003998:Dicarboxylic Acids; D011196:Potassium Permanganate; D002857:Chromium; D007854:Lead; D002563:Cerium; D013012:Sorbitol; D014001:Tin; D007505:Iron-Dextran Complex; D000535:Aluminum; D007501:Iron; D002122:Calcium Chloride